Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Research Communications is Scopus-indexed (Q2, CiteScore 5.4), WoS ESCI, DOAJ. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 2767-9764Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 136 / 428 | 68th | Q2 |
| Cancer Research | 112 / 233 | 51st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 5.4.
Cancer Research Communications is Q2 in Oncology (rank 136 of 428) and Q2 in Cancer Research (rank 112 of 233), by CiteScore 2025.
Cancer Research Communications is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.4, which places it in quartile Q2 at the 68th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.773, quartile Q1, with an H-index of 22.
The publisher lists an article processing charge of about US$2,550 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Research Communications is published by American Association for Cancer Research Inc. Its ISSN is 2767-9764.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Research Communications has an h-index of 32 and a 2-year mean of 4.56 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #67 of 424 Scopus journals in Oncology.
Cancer Research Communications published 193 papers in 2025; its busiest recent year was 2024 with 254. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2026), authors are most often from United States (62.1%), Japan (4.5%) and France (3.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.